Lv 201466. Lv K, Guo HM, Lu YJ, Wu ZX, Zhang K, Han JK. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: Comparison with MRI findings. Nucl Med Commun. 2014;35(12):1204-1211. doi:10.1097/MNM.0000000000000198 https://doi.org/10.1097/MNM.000000000000...
|
Y |
Y |
Y |
N |
Y |
Y |
N |
Y |
NA |
N |
Kitajima201477. Kitajima K, Suenaga Y, Ueno Y, et al. Fusion of PET and MRI for staging of uterine cervical cancer: Comparison with contrast-enhanced18F-FDG PET/CT and pelvic MRI. Clin Imaging. 2014;38(4):464-469. doi:10.1016/j.clinimag.2014.02.006 https://doi.org/10.1016/j.clinimag.2014....
|
Y |
Y |
Y |
N |
NA |
Y |
N |
Y |
NA |
N |
Perezmedina201388. Perez-Medina T, Pereira A, Mucientes J, et al. Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma. Int J Gynecol Cancer. 2013;23(1):170-175. doi:10.1097/IGC.0b013e3182784289 https://doi.org/10.1097/IGC.0b013e318278...
|
Y |
Y |
Y |
N |
Y |
N |
Y |
Y |
Y |
N |
Monteil201199. Monteil J, Maubon A, Leobon S, et al. Lymph node assessment with 18F-FDG-PET and MRI in uterine cervical cancer. Anticancer Res. 2011;31(11):3865-3871.
|
Y |
Y |
Y |
N |
NA |
N |
N |
Y |
N |
Y |
Park20051010. Park W, Park YJ, Huh SJ, et al. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer. Jpn J Clin Oncol. 2005;35(5):260-264. doi:10.1093/jjco/hyi079 https://doi.org/10.1093/jjco/hyi079...
|
Y |
Y |
Y |
N |
NA |
Y |
Y |
Y |
NA |
Y |
Ma20031111. Ma S-Y, See L-C, Lai C-H, et al. Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med. 2003;44(11):1775-1783. http://www.ncbi.nlm.nih.gov/pubmed/14602859. http://www.ncbi.nlm.nih.gov/pubmed/14602...
|
Y |
Y |
Y |
N |
Y |
Y |
Y |
Y |
NA |
Y |
Reinhardt20011212. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology. 2001;218(3):776-782. doi:10.1148/radiology.218.3.r01mr19776 https://doi.org/10.1148/radiology.218.3....
|
Y |
Y |
Y |
N |
Y |
Y |
Y |
Y |
NA |
Y |
Choi20061313. Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: A prospective study. Cancer. 2006;106(4):914-922. doi:10.1002/cncr.21641 https://doi.org/10.1002/cncr.21641...
|
Y |
Y |
Y |
N |
NA |
N |
N |
Y |
NA |
Y |
Chou20101414. Chou H-H, Chang H-P, Lai C-H, et al. (18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma. Eur J Nucl Med Mol Imaging. 2010;37(4):728-735. doi:10.1007/s00259-009-1336-1 https://doi.org/10.1007/s00259-009-1336-...
|
Y |
Y |
Y |
N |
Y |
Y |
N |
Y |
NA |
Y |
Yen20031515. Yen TC, Ng KK, Ma SY, et al. Value of dual-phase 2-fluoro-2-deoxy-D-glucose positron emission tomography in cervical cancer. J Clin Oncol. 2003;21(19):3651-3658. doi:10.1200/JCO.2003.01.102 https://doi.org/10.1200/JCO.2003.01.102...
|
Y |
Y |
Y |
N |
Y |
Y |
Y |
Y |
NA |
Y |
Belhocine 20021616. Belhocine T, Thille A, Fridman V, et al. Contribution of whole-body18FDG PET imaging in the management of cervical cancer. Gynecol Oncol. 2002;87(1):90-97. doi:10.1006/gyno.2002.6769 https://doi.org/10.1006/gyno.2002.6769...
|
N |
Y |
Y |
Y |
Y |
N |
Y |
N |
Y |
Y |
Bjurberg20131717. Bjurberg M, Brun E. Clinical impact of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri. Int J Gynecol Cancer. 2013;23(9):1642-1646. doi:10.1097/IGC.0b013e3182a50537 https://doi.org/10.1097/IGC.0b013e3182a5...
|
Y |
Y |
Y |
N |
Y |
N |
N |
N |
N |
Y |
Pallardy20101818. Pallardy A, Bodet-Milin C, Oudoux A, et al. Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma. Eur J Nucl Med Mol Imaging. 2010;37(7):1270-1278. doi:10.1007/s00259-010-1417-1 https://doi.org/10.1007/s00259-010-1417-...
|
Y |
Y |
Y |
N |
Y |
N |
Y |
Y |
N |
Y |
Lin20061919. Lin CT, Yen TC, Chang TC, et al. Role of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in re-recurrent cervical cancer. Int J Gynecol Cancer. 2006;16(6):1994-2003. doi:10.1111/j.1525-1438.2006.00729.x https://doi.org/10.1111/j.1525-1438.2006...
|
Y |
Y |
Y |
N |
Y |
Y |
N |
Y |
NA |
N |
Yen20042323. Yen T, See L, Chang T, et al. Defining the Priority of Using 18 F-FDG PET for recurrent cervical cancer.. 2004;45(10):1632-1640.
|
Y |
Y |
Y |
N |
NA |
Y |
Y |
Y |
NA |
Y |
Lai20042121. Lai C-H, Huang K-G, See L-C, et al. Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography. Cancer. 2004;100(3):544-552. doi:10.1002/cncr.11928 https://doi.org/10.1002/cncr.11928...
|
Y |
Y |
Y |
N |
Y |
Y |
Y |
Y |
NA |
Y |
Park20002222. Park DH, Kim KH, Park SY, Lee BH, Choi CW, Chin SY. Diagnosis of Recurrent Uterine Cervical Cancer: Computed Tomography versus Positron Emission Tomography. Korean J Radiol. 2000;1(1):51-55. doi:10.3348/kjr.2000.1.1.51 https://doi.org/10.3348/kjr.2000.1.1.51...
|
Y |
Y |
Y |
N |
Y |
Y |
Y |
Y |
NA |
Y |